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Abstract The role for lifestyle modifications to correct
dyslipidemia(s) is reviewed. Dietary composition is crucial.
Replacing saturated fat withMUFA or n-6 PUFA lowers plasma
low-density lipoproteins (LDL) cholesterol and ameliorates the
LDL/HDL ratio. Replacing saturated fat with carbohydrates has
diverging effects due to the heterogeneity of carbohydrate foods.
Diets rich in refined carbohydrates increase fasting and post-
prandial triglycerides, whereas the consumption of fiber-rich,
lowGI foods lowers LDL cholesterol with no detrimental effects
on triglycerides. The role of polyphenols is debated: available
evidence suggests a lowering effect of polyphenol-rich foods on
postprandial triglycerides. As for functional foods, health claims
on a cholesterol lowering effect of psyllium, beta-glucans and
phytosterols are accepted by regulatory agencies. The impor-
tance of alcohol intake, weight reduction, and physical activity
is discussed. In conclusion, there is evidence that lifestyle affects
plasma lipid. A multifactorial approach including multiple
changes with additive effects is the best option. This may also
ensure feasibility and durability. The traditional Mediterranean
way of life can represent a useful model.
Keywords Dyslipidemias . LDL cholesterol . Cardiovascular
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Introduction
Lifestyle intervention plays an important role in the pre-
vention of atherosclerotic cardiovascular diseases. It can
influence atherogenesis directly or through effects on car-
diovascular risk factors such as plasma lipids, blood pres-
sure, or plasma glucose levels [1]. In particular, a large
body of data has accumulated during the last 50 years on
the impact of different dietary measures and regular phys-
ical activity on plasma lipoprotein metabolism. On the
overall, the evidence supports the efficacy of lifestyle
modifications in improving the plasma lipoprotein profile
and reducing the incidence of cardiovascular diseases
(CVD) [2, 3].
It is well established that low-density lipoproteins
(LDL) contribute to the development of atherosclerosis
over and above the influence of other known risk factors.
Triglyceride-rich lipoproteins, particularly in diabetic pa-
tients and in people with metabolic syndrome, are also
associated with an increased cardiovascular risk, while
high-density lipoprotein (HDL) cholesterol levels are in-
versely associated with CVD in prospective studies [2].
A meta-analysis of intervention studies on the relation-
ship between improvement of the plasma lipoprotein pro-
file and incidence of cardiovascular events has demon-
strated that lowering non-HDL cholesterol translates into
reduction of CV incidence independently of the mecha-
nisms involved (i.e., dietary interventions, use of statins,
resins, or ileal bypass) [4]. This emphasizes the oppor-
tunity to implement lifestyle modifications aimed at re-
ducing LDL and non-HDL cholesterol at the population
level in people at moderate cardiovascular risk—as the
only therapeutic intervention—and in people at high
cardiovascular risk—in addition to the pharmacological
treatment [2, 3].
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Dietary Fat Composition
The impact of dietary fat modifications on the plasma lipopro-
tein profile is summarized in a meta-analysis of 27 well con-
ducted, controlled dietary intervention trials lasting 3 to
8 weeks. The relationship between diet composition and
changes in plasma concentrations of the major lipoprotein
classes is consistent and reproducible to the point that from
these data, a set of mathematical equations were derived to
predict the magnitude of the change(s) in plasma lipoprotein
levels in response to specific dietary fat change(s) [5].
According to these equations, the amount of saturated fat in
the diet and, in particular, that of fatty acids with 12–16 carbon
atoms has the strongest impact on plasma LDL cholesterol
levels. The estimated increase in LDL cholesterol for each
additional 1 % energy from saturated fat is 0.8–1.6 mg/dL
(0.02–0.04 mmol/L). On the contrary, LDL cholesterol de-
creases by 2.0 mg/dL (0.051 mmol/L) for each 1 % of satu-
rated fatty acid (SFA) intake replaced with n-6 polyunsaturat-
ed fat (PUFA), by 1.6 mg/dL (0.041 mmol/L) for the replace-
ment with monounsaturated fatty acid (MUFA) and by
1.2 mg/dL (0.032 mmol/L) for the replacement with
carbohydrate.
As for HDL cholesterol, substituting MUFA for SFA has a
small or no effect, whereas n-6 PUFA induces a slight de-
crease of this lipoprotein class; however, both types of unsat-
urated fat reduce the LDL/HDL cholesterol ratio and lower
plasma triglycerides, thus improving the overall cardiovascu-
lar risk associated with the plasma lipoprotein profile. The
high quality and the large number of the individual studies
reviewed make these predictions very reliable [5].
The high consistency of the evidence has prompted the
European Food Safety Authority (EFSA)—an independent
and authoritative body appointed by the European Community
to issue opinions on the scientific substantiation of health
claims—to state that BConsumption of saturated fat increases
blood cholesterol concentrations; consumption of mono- and/
or polyunsaturated fat in replacement of saturated fat has been
shown to lower/reduce blood cholesterol. Blood cholesterol
lowering may reduce the risk of (coronary) heart disease^ [6].
Substitution of saturated fat with MUFA or n-6 PUFA im-
proves also other cardiovascular risk factors (RF) in particular,
insulin sensitivity, blood pressure, subclinical inflammation,
and endothelial dysfunction [7, 8].
Trans-fatty acids in the diet are largely of industrial origin.
They have quantitatively similar raising effects on LDL cho-
lesterol as SFAs, but unlike SFAs, they also decrease HDL
cholesterol levels, with an additional detrimental effect on
the LDL/HDL ratio [5].
In most industrialized countries, the food industry has
largely eliminated the trans-fatty acids from food production,
thus greatly reducing their consumption at the population lev-
el. This measure may contribute to the improvement of the
plasma lipid profile and the prevention of CVD.
Unfortunately, the intake of trans-fatty acids remains too high
in many developing countries and further actions are needed
to restrict or completely eliminate their use. Several experi-
mental studies in humans have evaluated the effects of dietary
cholesterol on cholesterol absorption and lipid metabolism
and have revealed a marked variability among individuals.
This variability is influenced both by the genetic back-
ground—among other polymorphisms in the cholesterol
transporters, ABCG5/8 and NPC1L1 play a significant
role—and by the composition of diet. In particular, a highly
saturated fat intake amplifies the ability of dietary cholesterol
to increase LDL cholesterol levels. Within the context of a diet
with a moderate content of saturated fat, the impact of dietary
cholesterol on LDL cholesterol is small. A greater impact,
however, is observed in people with marked hypercholester-
olemia [9].
Amount and Type of Carbohydrate-Rich Foods
Replacement of foods high in saturated fat in the diet can be
achieved either by unsaturated fat or by carbohydrate-rich
foods. Carbohydrate intake represents a controversial issue
in relation to the impact on plasma lipoprotein metabolism
and on CVD prevention partly due to the heterogeneity of
carbohydrate food sources. Carbohydrate foods may differ
for their chemical composit ion (starch vs mono-
disaccharides) but also for their physical form and for the
amount and/or types of other bioactive food ingredients (i.e.,
fiber, polyphenols). Very often, this heterogeneity and the
sometimes diverging metabolic effects of different
carbohydrate-rich foods are not properly accounted for when
evaluating the impact of carbohydrates on plasma lipid levels
and other cardiovascular risk factors.
In fact, the influence of carbohydrate-rich foods on lipo-
protein metabolism depends not only on their amount but also
on specific food features that influence carbohydrate digest-
ibility and the absorption of other nutrients. This has raised
much interest in food properties able to retard the carbohy-
drate digestion and absorption in the intestine. In this context,
not only the carbohydrate type (mono-disaccharides or
polysaccharides) but also the content of fiber and other food
constituents modulate the postprandial glucose rise. In partic-
ular, viscosity plays an important role, since it delays gastric
emptying and hampers the mixing of the intestinal content,
thus decreasing the rate of glucose transport to the enterocytes.
All these different food features that influence carbohydrate
digestibility and, hence, the postprandial metabolic response
are somewhat accounted for by the measurement of the gly-
cemic index (GI). This is conceptually the glycemic response
elicited by a portion of food containing 50 g of available
carbohydrate expressed as a percentage of the glucose re-
sponse elicited by 50 g of glucose. The preferential
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consumption of low glycemic index foods counteracts the
possible untoward effects of a highly refined carbohydrate diet
on fasting and postprandial plasma triglycerides and on HDL
[10•, 11].
Dietary Fiber
Pioneer studies with diets rich in dietary fiber and composed
only of natural foods clearly indicate that these diets, especial-
ly if rich in soluble fiber, significantly reduce LDL-cholesterol
levels in hyperlipidemic and type 2 diabetic patients [12]. The
net LDL-cholesterol reduction due to changes in fiber intake
can be as high as 10 %. Furthermore it has to be considered
that fiber rich foods are generally used as substitutes for food
sources of saturated fat and this leads to an additional decrease
in LDL cholesterol levels [13].
The beneficial effects of high-fiber diets on LDL cholester-
ol have been recently confirmed by a meta-analysis compar-
ing the effects of low-GI vs high-GI diets. The significant
decrease in LDL cholesterol observed with the low-GI diets
was related to their fiber content and, in fact, it was not any
more evident when studies with high-fiber diets were exclud-
ed from the analysis [14]. The hypocholesterolemic effect of
dietary fiber has been mainly ascribed to soluble fiber such as
pectin, guar gum, psyllium which are found in fruits, vegeta-
bles and legumes, or beta-glucans which are found in some
cereals (oats and barley) [15, 16].
In particular, for pectin and psyllium, different meta-
analyses show that an average intake of 7–10 g/day reduces
total and LDL-cholesterol levels by 0.13 mmol/l [15]. In line
with this observation, intervention studies with diets rich in
pulses, foods with a high content of pectin, gum, and psyllium
show a significant reduction of LDL cholesterol [16]. Of
course, other components present in these foods (i.e., phyto-
estrogen, polyphenols) may also play a role.
Also for beta-glucans, a meta-analysis of intervention stud-
ies shows a significant reduction of LDL cholesterol by as
much as 6 % with an average daily dosage of at least 3 g/
day [17•].
The effect of dietary fiber on plasma triglyceride levels is
less clear. Dietary fiber seems able to counteract the rising
effect of carbohydrates on fasting triglycerides [13]. In the last
years, much attention has been paid to postprandial lipemia as
a cardiovascular risk factor and, indeed, large epidemiological
studies suggest that postprandial triglycerides are a stronger
CV risk factor than fasting triglyceride levels [18]. Different
dietary components modulate the postprandial triglyceride re-
sponse. Recently, much attention has been devoted to the ef-
fects of dietary fiber on postprandial triglycerides. Our group
has shown that in people with type 2 diabetes, a fiber-rich diet
(fruit, vegetable, legumes, whole grains) reduces the postpran-
dial triglyceride response, mainly due to the reduction of lipo-
proteins carrying exogenous lipids [19]. On the same line, we
have shown that in people with the metabolic syndrome a diet
based on wholegrain cereals, as compared to a diet with re-
fined cereals, reduces postprandial triglyceride levels by 40 %
[20•]. In this study, the decrease in postprandial triglycerides
was significantly and inversely correlated with the intake of
cereal fiber, supporting the role of cereal fiber in the modula-
tion of the postprandial metabolism.
The effects of dietary fiber on HDL are negligible.
Together with the reduction of LDL cholesterol, a small de-
crease in HDL cholesterol has been reported with high-fiber
diets in some studies; however, on the overall, the magnitude
of this effect is much less relevant than that obtained on LDL
cholesterol. In addition, dietary fiber is able to counteract to a
variable extent the decrease in HDL cholesterol induced by
high-carbohydrate foods [21].
Dietary fiber may act on lipid metabolism, in particu-
lar on LDL cholesterol, through different mechanisms:
slowing cholesterol absorption in the intestine, increasing
bile acid excretion, producing in the colon short-chain
fatty acids that, in turn, inhibit hepatic cholesterol syn-
thesis [15].
With respect to the effects on postprandial triglycerides, it
has been suggested that dietary fiber slows down and reduce
the absorption of fat in the small intestine, thus decreasing the
production of chylomicrons [22].
Simple and Added Sugars
Within the carbohydrates, a particular attention has to be paid
to simple sugars and, particularly, to fructose, which, although
characterized by a low glycemic index, has many adverse
effects on lipid metabolism. Prospective studies indicate that
a high intake of sugar-sweetened beverages, containing either
sucrose or fructose, is associated with an increased risk of
metabolic and cardiovascular diseases (obesity, type 2 diabe-
tes, hypertension, and coronary heart disease) [23, 24]. On the
same line, observational and intervention studies show that
while low-to-moderate doses of fructose (∼10 % of total en-
ergy) have no major impact on carbohydrate and lipid metab-
olism, higher doses increase fasting and postprandial triglyc-
eride levels, especially in subjects with obesity and hypertri-
glyceridemia [25, 26•].
In conclusion, the available evidence indicates that a
high amount of refined carbohydrates in the habitual diet
is generally associated with untoward effects on fasting
and postprandial lipoprotein levels and ultimately on
CVD risk. Therefore, dietary recommendations for the
prevention of cardiovascular disease strongly suggest to
increase the consumption of fiber-rich and low-GI foods
such as vegetables, fruits, whole grains, and legumes, and
to limit the intake of sugar-sweetened beverages, sweets,
and other foods rich in added sugar [2, 3].
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Other Bioactive Compounds Able to Influence Lipid
Metabolism
In recent years, much attention has been paid to other food
constituents that were neglected in the past since they are
present in foods in very small amounts. Among them, the
polyphenols have been extensively studied for their impact
on cardiovascular diseases and, more in general, on human
health.
These substances are mainly present in foods like vegeta-
bles, fruits, legumes, whole cereals, and nuts, all of which
have been associated with a reduction in CVD risk.
Polyphenols may contribute, at least in part, to the health
benefits of these foods. They are a very large and complex
family of compounds present in virtually all plant foods and in
plant-derived beverages, particularly coffee and green tea,
wine, and in cocoa/chocolate [27].
Polyphenols and foods rich in these substances may reduce
cardiovascular risk by modulating lipid metabolism. In vitro
and animal studies have shown that polyphenols decrease Apo
B-containing lipoproteins and increase HDL cholesterol
levels. This is particularly true for proanthocyanidins that rep-
resent one of the most abundant polyphenols in the human
diet. However, intervention trials conducted in humans have
produced inconsistent results. The differences in the study
outcomes have been mainly ascribed to differences in the
methodology (i.e., different compounds were tested at differ-
ent doses) [28].
Dark chocolate and cocoa products, rich in polyphenols but
containing also other substances able to influence lipid metab-
olism, seem to have a more evident hypocholesterolemic ef-
fect. A meta-analysis of intervention studies in humans shows
a significant decrease in LDL cholesterol in short-term stud-
ies, whereas studies of longer duration do not confirm the
effects of cocoa on LDL cholesterol and on other lipoprotein
classes [29, 30].
Against this background, we tried a more comprehen-
sive approach to evaluate the effects of polyphenol-rich
foods on plasma lipoprotein metabolism. Therefore, rather
than single molecules, we tested a whole diet that includ-
ed foods rich in different types of polyphenols. The
polyphenol-rich diet was evaluated in a controlled inter-
vention study of medium term duration and was able to
significantly reduce plasma triglycerides at fasting and in
the postprandial period. No effects were observed on LDL
and HDL cholesterol [31•].
In conclusion, data on polyphenols and cardiovascular
risk are not at all conclusive and controlled intervention
studies of long duration in humans are needed. At this
stage, it is however reasonable to recommend the con-
sumption of foods rich in polyphenols because they are
associated with clinical benefits on many cardiovascular
risk factors [32•].
The Role of Functional Foods
Emerging evidence supports the role for Bfunctional foods^ as
part of the lifestyle intervention to treat dyslipidemias.
Consumption of foods with added plant sterols/stanols, or
soluble (viscous) fiber, such as those contained in oats or
barley, is associated with a significant reduction in LDL cho-
lesterol, and therefore may have a role in the management of
patients whose absolute cardiovascular risk assessment does
not justify the use of pharmacotherapy. Alternatively, it may
be used on top of pharmacotherapy in people with a high
cardiovascular risk and plasma lipid levels not at target.
Unfortunately, none of these dietary supplements has been
tested in formal RCT with CVD end points.
Phytosterols compete with cholesterol for the intestinal ab-
sorption, thus reducing LDL cholesterol levels. Phytosterols
have been added to different foods (yogurt, spreads, and veg-
etable oils); however, the food matrix does not significantly
influence the cholesterol-lowering efficacy of phytosterols at
equivalent doses [33]. In order to achieve a clinically relevant
hypocholesterolemic effect (i.e., 7–10 % reduction) a daily
dose of 2 g consumed preferably with themain meal is needed.
This dosage has little or no effect on HDL-C and TG levels.
A recent meta-analysis of intervention trials on the effects
of fiber supplements on plasma cholesterol levels clearly dem-
onstrates that pectin and psyllium as well as beta-glucans from
either whole oats or barley induce a significant reduction of
LDL cholesterol levels [34].
On the basis of the abovementioned evidence, health
claims on a reduction of LDL cholesterol levels by nearly
5 % with the supplement of 7 g/day of psyllium or 3 g/
day of beta-glucans have been accepted by FDA and
EFSA [35, 36].
Weight Reduction, Alcohol and Habitual Physical Activity
Studies evaluating the effects of weight reduction on plasma
lipoprotein metabolism indicate that weight loss is associated
with a modest, but statistically significant, decrease in total
and LDL cholesterol together with more pronounced effects
on plasma triglyceride levels and HDL.
A meta-analysis of intervention studies [37] aiming at
weight reduction showed that weight loss per se (average
16 kg or 16% from baseline weight) is associated with a mean
decrease in plasma total cholesterol of 30 mg/dL, due to the
reduction of both LDL and VLDL cholesterol in equal pro-
portions. Weight reduction is significantly correlated with the
decrease of LDL and VLDL cholesterol and triglyceride con-
centrations. For each kilogram decrease in body weight, total
and LDL cholesterol decrease by 2 and 0.8 mg/dL, respective-
ly. Furthermore, a 0.3-mg/dL reduction in HDL cholesterol
occurs for subjects who actively lose weight, whereas a 0.4-
mg/dL increase occurs for subjects at a stabilized weight
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reduction. Improvements in HDL cholesterol and in plasma
triglycerides tend to be greater in overweight or obese subjects
on low-carbohydrate diets, whereas changes in LDL choles-
terol levels are more favorable in subjects on low-fat diets
[38].
From a practical point of view, weight reduction may be
achieved by reducing the consumption of energy-dense
foods, especially those rich in fat, to achieve a caloric def-
icit of 300–500 kcal/day. To maintain its effectiveness on
the long run, this intervention should be incorporated into
structured, intensive lifestyle education programs. The pre-
scription of a very low energy diet should be limited to
cases with severe obesity (BMI >35 kg/m2) and adminis-
tered in specialized centers [2].
Alcohol consumption has a neutral effect on LDL cho-
lesterol and a possible positive impact on HDL cholester-
ol levels [39] but is associated with untoward effects on
triglycerides levels. The intake of 40–60 g/day of alcohol
is associated with a significant increase in plasma triglyc-
erides particularly in obese or hypertriglyceridemic
people.
Moderate-to-heavy aerobic exercise is associated with
an improvement in the plasma lipid profile. Both plasma
triglyceride reductions and an increase of HDL cholesterol
are observed after exercise training. An energy expenditure
of 1200 to 2200 kcal/week is associated a with reduction of
5 to 38 mg/dL of plasma triglycerides and an increase of 2
to 8 mg/dL in HDL cholesterol. Evidence from cross-
sectional studies indicates that greater changes in HDL
cholesterol levels and plasma triglycerides can be expected
with additional increases in exercise training volume.
Exercise training seldom alters total cholesterol and LDL-
cholesterol, unless weight loss is associated with the exer-
cise training program [38].
Implementation of Lifestyle Modification to Control
Dyslipidemias
According to current dietary guidelines for CVD prevention,
the most relevant dietary modification to improve the plasma
lipoprotein profile is the reduction of trans- and saturated fat
(SFA) (i.e., butter, cream, hard margarines, and tropical oils)
that should be replaced, by monounsaturated (MUFA) and
polyunsaturated fats (PUFA) from non-tropical vegetable oils.
The target is to keep the energy intake from saturated fat to
<10 % (<7 % in the presence of high plasma cholesterol
values) and trans-fats to <1.0 % of total energy. In order to
reach this goal, also fatty or processed meat, sweets, regular
cheese should be limited while fruits, vegetables, legumes,
nuts, and wholegrain cereal foods should be preferred. The
latter ones represent an important source of dietary fiber and
polyphenols that, as outlined above, have additional beneficial
effects on plasma lipoproteins [2, 3].
Other features of the recommended diet for CVD pre-
vention are a low salt intake (below 5 g/day), moderation
in the consumption of alcoholic beverages (<10 g/day for
women and <20 g/day for men) and limitation in the intake
of beverages and foods with added sugars, particularly soft
drinks. Moreover, special attention should be paid to the
energy intake in order to reduce the occurrence of over-
weight and obesity [2, 3].
These recommendations are mostly based on solid evi-
dence coming from prospective observational reports and
clinical studies evaluating the impact of diet on cardiovascular
risk factors [1, 39, 40]. However, also the few available ran-
domized controlled clinical trials (RCT) with hard end points
(i.e., CVevents), although not always consistent, indicate that
the so called healthy diet is effective in reducing the incidence
of cardiovascular events [41]. In this respect, it is always im-
portant to consider that dietary intervention studies are much
more complex than pharmacological trials, and failure to
achieve substantial modifications in the habitual diet is often
a plausible explanation for the lack of effects on the study
outcomes. Moreover, dietary interventions are necessarily
multifactorial since it is not possible to change a single dietary
constituent without modifying at the same time other features
of the diet. Therefore, the results of studies evaluating changes
in the habitual diet need to be evaluated taking into account
Fig. 1 Effects on LDL cholesterol levels of a 3-month dietary
intervention based on the substitution of 10% energy from saturated with
monounsaturated fat in 162 healthy subjects. The KANWU study
(modified from reference [43])
Table 1 LDL-cholesterol reduction by multiple lifestyle modifications
Intervention LDL cholesterol reduction
Saturated fat reduction (↓ 10 %) 10 %
Dietary fiber increase (15–20 g) 8 %
Weight reduction (5 kg) −5 %
Foods enriched with phytosterols (2 g) 10 %
30–35 %
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the complexity of the intervention and the nature of all mod-
ifications of the food choices undertaken.
Despite these methodological difficulties, new evi-
dence from RCT supports the concept that CVD can be
effectively prevented by appropriate diet modifications
[2]. Recently, the results of a randomized controlled trial
conducted in high-risk individuals have clearly shown that
a Mediterranean diet, resembling food choices highlighted
in most recent recommendations for CVD prevention,
lowers by 29 % (RR 0.71; 95 % CI 0.56–0.90) the inci-
dence of cardiovascular disease over a 5-year period in
comparison with a low-fat diet traditionally considered
as the gold standard [42].
Criticisms to the use of lifestyle interventions for control-
ling dyslipidemias arise from the difficulty to achieve changes
that may last in the long term and from doubts on the clinical
relevance of the magnitude of the lipoprotein changes that can
be achieved.
As for the last point, it is clear from the evidence
reviewed here that although each single lifestyle modifica-
tion has a rather modest impact on plasma lipoprotein
levels and, in particular, on LDL cholesterol, the
combination of different measures may have a clear clini-
cal relevance. Reducing by 10 %, the amount of saturated
fat in the diet leads to an LDL cholesterol reduction of
around 10 % (Fig. 1) [43] and summing it up to the ef-
fect(s) of other diet modifications (i.e., increase of dietary
fiber, weight reduction, and the daily consumption of phy-
tosterol supplements), the impact on LDL cholesterol can
be meaningful (Table 1). The additive effects of lifestyle
changes have been clearly demonstrated by a study in
which a so-called portfolio diet was tested. Indeed, adop-
tion of this type of diet that included plant sterols, viscous
fiber, soy proteins, and nuts had cumulative LDL
cholesterol-lowering benefits reaching an overall reduction
of 20–30 %, which represent a meaningful approach to the
reduction of CVD risk [44•]. Appropriate food choices
aiming at reducing simple sugar intake and at increasing
food sources of polyphenols together with regular exercise
of moderate intensity may also have a favorable impact on
other lipoprotein classes, namely triglyceride-rich lipopro-
teins and HDL.
As for the feasibility of lifestyle changes in the long
term, significant declines in saturated fat intake and recip-
rocal increases in polyunsaturated fat were implemented at
the population level between 1990 and 2010 in many
Eastern and Northern European countries. This demon-
strates the feasibility at the level of the general population
of lifestyle modifications aiming at reducing LDL choles-
terol and at improving the overall lipoprotein profile. The
decrease of the saturated fat consumption started in the
second half of the last century in most European countries
as indicated by crude national availability and production
estimates. Finland constitutes one of the best documented
examples of a community intervention that had most of its
effect prior to 1990, with further (though smaller) declines
Table 2 Foods available for consumption in Finland in the second half
of the last century
g/day 1960 1970 1980 1990 2000
Animal fat 59 59 51 39 34
Vegetable oils 9 16 20 22 26
Vegetables 50 55 96 156 195
Fruit 114 141 243 216 225
Fish 47 61 77 88 86
FAO food balance sheets
Fig. 2 The impact of lifestyle
modifications on plasma lipids
and CVD risk
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seen after that [45]. The major pillars of this intervention
included the transition from consumption of fatty milk to
low fat and skimmed milk, a large reduction in butter con-
sumption, and a marked increase in the use of vegetables
and vegetable oils (Table 2). Dietary changes were
paralleled by a constant decline of serum cholesterol
levels; at the population level over 80 % of the cholesterol
reduction was due to dietary changes, and only less than
20 % to the use of statins; these drugs become available
only 10 years after the plasma cholesterol decline had
started [46].
Additional key issues concerning the implementation of
lifestyle modifications are (1) long-term adherence and (2)
economical costs. Addressing the question of how to ensure
sustainable dietary changes must be a priority for research.
Furthermore, in the current austerity climate in Europe, cost
may detrimentally influence the choice of a Mediterranean
diet. Both challenges require the involvement of public health
researchers and policy makers to ensure the benefits of dietary
intervention are optimized.
Conclusions
Taking into consideration the whole available evidence, it
is clear that lifestyle modifications can be very effective
in controlling dyslipidemias. In this respect, a multifacto-
rial approach seems the best option since it can combine
multiple small variations in the habitual behaviors that are
more feasible and durable than a single, more radical
change and that in addition have additive effects on the
amelioration of the plasma lipoprotein profile (Fig. 2).
This approach is of major clinical relevance both for peo-
ple who do not need pharmacological treatment—in view
of their low/moderate absolute CVD risk—and for those
who are on hypolipidemic drugs since they can get extra
benefits from appropriate lifestyle changes. The tradition-
al Mediterranean way of life can represent a useful model
to implement dietary changes and other lifestyle modifi-
cations that are healthy and, at the same time, is based on
a solid cultural and gastronomic background that facili-
tates its implementation on the basis not only of its health
benefits but also in consideration of its palatability and
appeal.
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